Introduction
The microdeletion 22q11.2 syndrome is one of the more common human deletion syndromes (1 in 4000 live births) 1 and encompasses several clinical entities. Between 35 and 90% of patients clinically diagnosed with DiGeorge Syndrome (consisting of cardiac abnormalities such as interrupted aortic arch, truncus arteriosus and tetralogy of Fallot; hypoparathyroidism; and thymic hypoplasia with secondary immunodeficiency) and 80-100% of those with velocardiofacial syndrome (consisting of pharyngeal dysfunction, cardiac anomalies, and dysmorphic facies) have this hemizygous deletion. [1] [2] [3] This deletion is also found in patients with CHARGE (coloboma, heart atresia, retardation of growth, genitourinary problems, and ear abnormalities) and conotruncal anomaly face syndromes. 1 The reason for these overlapping syndromes is the enormous phenotypic heterogeneity found with mutations of chromosome 22q11.2. DiGeorge syndrome was first described in 1968 as a defect affecting structures derived from the third and fourth embryonic pharyngeal arches and pouches with absent or small parathyroid glands. 4 Many affected individuals die in the neonatal period because of cardiac anomalies and susceptibility to infections. Cardiac defects are found in 75% of patients.
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Information concerning the neurologic manifestations of patients with 22q11.2 deletion who survive into adulthood is scarce. We report a case of an individual with DiGeorge syndrome whose seizures began in childhood and continued into the adult years and present the EEG findings. The information garnered from this case provides additional clinical insights on this relatively common condition.
Case report
A 21-year-old female was referred to our service due to seizures. She was born full-term, weighing 9-pounds and her mother had an unremarkable pregnancy. However, during delivery she became severely cyanotic. She was diagnosed as having both Atrial Septal Defect (ASD) and Ventricular Septal Defect (VSD), and these were repaired at 2 months of age. There was a question of ''seizure-like'' activity during her first year of life and the patient was briefly placed on phenobarbital but this was subsequently discontinued.
Her early medical history was significant for mild psychomotor retardation and the patient required special education. When the patient was 9 years old she began to have generalized tonic-clonic seizures lasting 2-3 min and occurring from wakefulness. At that time, she was also diagnosed as having hypocalcaemia secondary to hypoparathyroidism (total serum calcium of 7.8 mg/dl; N = 9-10.5). Physical examination was remarkable for a short stature as well as mild facial abnormalities such as micrognathia, hypertelorism, and the absence of tonsils. A clinical suspicion of DiGeorge This is the first case report to describe the EEG findings in a patient with DiGeorge syndrome who survived into adulthood. The patient developed generalized tonic-clonic seizures when she was 9 years old and these were associated with hypocalcemia. Despite treatment with calcium, seizures persisted and the patient required antiepileptic medications. She was eventually controlled with oxcarbazepine. An MRI of the head was normal. An EEG showed independent spike and wave discharges emanating from the left temporal and right frontal region. The presence of focal findings on EEG, the lack of complete response to calcium therapy, and the need for antiepileptic drug therapy indicate that some of these patients may be inherently predisposed to developing epilepsy.
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syndrome arose and the chromosome 22q11.2 deletion was confirmed via FISH probe. Her parents were also tested for the genetic deletion but the results were negative. There was no family history of epilepsy. The patient began treatment with calcium carbonate and calcitriol. Despite the correction of her serum calcium, she continued having seizures and was later placed on antiepileptic medications including phenytoin, carbamazepine, and lamotrigine, all of which were associated with significant sedation and continuing seizures. Since 18 years of age, she has been on oxcarbazepine monotherapy, with good seizure control and tolerability.
A recent total calcium level was 8.1 mg/dl. The ionized calcium was 3.6 mg/dl (N = 4.5-5.6) and the urine calcium/creatinine ratio remained low despite medical treatment. A recent MRI of the brain was normal. Her recent EEG showed independent spike and wave discharges that emanated from the right temporal and the left frontal area (Fig. 1) . These abnormalities persisted despite the patient having had no seizures for 3 years.
Discussion
DiGeorge syndrome is a clinically variable syndrome consisting of more than 180 potential clinical expressions. 6 Due to its enormous potential phenotypic expression, the diagnosis can be challenging. However, the presence of cardiac defects, the predisposition towards recurrent infections, and the presence of distinct facial features allow the diagnosis to be usually made in early infancy. Although the majority of cases are due to a partial deletion of chromosome 22, several patients with the clinical phenotype of DiGeorge syndrome have no known cause. 1 The diagnosis entails a high clinical suspicious and the microdeletion in chromosome 22 can be readily detected in both the prenatal and postnatal periods by commercially available fluorescent in-situ hybridization (FISH) probes. 2 Hypoparathyroidism is a common clinical manifestation in 22q11.2 deletion syndrome. It has been reported in 40-75% of patients 2, 7 and is caused by absent or small parathyroid glands and usually presents in the neonatal period as hypocalcemia. Al-Jenaidi et al. 4 described 18 pediatric patients with 22q11.2 deletion syndrome and hypoparathyroidism; of these 11 had complete hypoparathyroidism while 7 had partial hypoparathyroidism. Eight patients (72%) with complete hypoparathyroidism had hypocalemic seizures, whereas only 2 patients with partial hypoparathyroidism (28%) presented with seizures secondary to low serum calcium levels. Cognitive disabilities are seen in 40-46% of individuals (higher in familial syndromes than in de novo deletions) and are accompanied by a delay in developmental and gross motor skills. 2 Behavioral problems include attention deficit-hyperactivity disorder, oppositional defiant disorder, anxiety, depression, social withdrawal, and obsessive-compulsiveness. Affected individuals have poor social skills and deficits in attention and thought. 2, 5 Structural neurological abnormalities include cerebral atrophy, cerebellar hypoplasia, cerebrovascular abnormalities, septum pellucidum cyst, hydrocephalus, hypoplastic corpus callosum, and the presence of enlarged ventricles. 6 Seizures are also commonly encountered in patients with the 22q11.2 deletion syndrome. Though generally regarded are being due to hypocalcemia, seizures also occur in normocalcemic individuals. Kao et al. 8 noted that the prevalence of a single unprovoked seizure was around 7% in patients with the 22q11.2 deletion syndrome. In a large European-based population, Ryan et al. 5 reported the presence of seizures in 21% of patients with the 22q11.2 deletion syndrome. Two-thirds of patients with seizures had documented hypocalcemia. Robin et al. 9 found seizures in 15/ 32 patients with the 22q11.2 deletion syndrome. Interestingly, none of these were associated with hypocalcemia. Cortical dysgenesis (specifically polymicrogyria) has been reported in some patients with the 22q11.2 deletion syndrome. The degree of polymicrogyria varies between both hemispheres but is more pronounced over the perisylvian region. Some of the clinical features of perisylvian polymicrogyria included cognitive defects, oromotor dysfunction (dyspraxia), dysarthria, dysphagia, drooling, and other signs of pseudobulbar palsy (9) .
It has also been shown that the regions of cortical dysgenesis in patients with the 22q11.2 deletion syndrome are inherently epileptic. Sztriha et al. 10 published the clinical and MRI findings correlation in two 5-year-old patients with polymicrogyria. One of their patients had refractory epilepsy and underwent a right functional hemispherectomy. This patient became seizure-free after surgery. In general, seizures are one of the more common symptoms associated with chromosomal abnormalities. Battaglia and Guerrini 11 reported that epilepsy occurs in up to half of cases with chromosomal deletion syndromes such as 1p36 deletion syndrome (craniofacial malformation and mental retardation) and 4p deletion syndrome (multiple congenital anomalities and mental retardation). Seizures are even more prevalent (90%) in cases of Angelman syndrome, an entity usually caused by a deletion of region 15q11-q13. In patients with trisomy 21 (Down's syndrome), epilepsy is documented in 5-10% of cases. In other cases, the incidence of epilepsy have been poorly defined, but reports of seizures have been documented in cases of trisomy 12p, trisomy 8q, ring chromosome 14 syndrome, and Inv-dup 15. 11, 12 In general, the clinical seizure pattern, age of onset, EEG findings, and response to antiepileptic therapy are variable and not necessarily associated with the severity of neuroimaging findings. The vast majority of reports describe the seizure activity of individuals with DiGeorge syndrome during their childhood years. Part of the reason for this is that patients with this condition rarely survive into adulthood. The 1-month mortality rate for this condition is 55% and a 6-month mortality rate of 86% has been reported, primarily due to congenital heart defects. 1, 6 Those who survive into adulthood tend to have milder cardiac defects, minimal facial dysmorphisms and a normal immune system but these represent less than 15% of the total cases. 1 To the best of our knowledge this is the first case report to describe both the ongoing seizure activity and EEG findings of an individual with DiGeorge syndrome during the adult years. Previous case reports have documented the progression of seizures during adulthood in patients with DiGeorge syndrome but did not include EEG findings. Kar et al. 13 reported one case of a 24-year-old woman with DiGeorge syndrome who had hypocalcemia but without cardiac abnormalities. Tonelli et al. 14 described a 40-year-old man who had convulsions associated with marked hypocalcemia. Seizures abated with normalization of his serum calcium levels. Maalouf et al. 15 described a 32-year-old man who had his first seizure at the age of 14 years that was associated with hypocalcaemia. The patient became asymptomatic with oral calcium replacement for the next 18 years until he discontinued his medications. He then developed recurrent seizures with hypocalcemia and chromosomal analysis then showed the chromosome 22q11.2 deletion. Hirotani et al. 16 reported a partial DiGeorge syndrome diagnosed at the age of 34 years, though generalized tonic-clonic seizures began when the patient was 3 years old. Coppola et al. 17 described the clinical and EEG findings of 2 pediatric patients with velocardiofacial syndrome. The first patient was a 12-year-old boy who began to have focal motor seizures when he was 5 years old. The EEG showed interictal epileptiform discharges emanating from the right centrotemporal region. Seizures continued until the patient was 12 years old and succeeding EEGs were normal. The second patient was a 6-yearold boy who began to have convulsive seizures when he has 3 years old. The EEGs showed occipital spike and wave discharges. Seizures were controlled with valproic acid. Roubertie et al. 18 also reported both the clinical and EEG findings of two pediatric patients with DiGeorge syndrome. The first patient was a neonate with symptomatic hypocalcemia, who had focal motor seizures and spike and wave discharges emanating from the right centroparietal region. This patient required calcium therapy as well as carbamazepine in order to achieve seizure control. The second patient was a 6-year-old girl with absence seizures and generalized 3-per-second spike and wave discharges. This patient was treated with valproic acid and clobazam. Kao et al. 8 indicated that the breath of EEG findings of patients with chromosome 22q11.2 deletion included both focal and multifocal epileptiform activity. Our patient had interictal epileptiform discharges emanating independently from the left frontal and right temporal regions. This finding suggests that our patient has localization-related epilepsy and that she may have more than one focus of seizure onset.
The presence of seizures in DiGeorge syndrome patients always obliges the physician to rule out and treat electrolyte abnormalities. However, as shown in our patient and in others, addressing the problem of hypocalcemia may not always result in complete seizure control, and AED therapy is sometimes required. Despite the normal MRI findings, the presence of persistent focal epileptiform discharges such as those seen in our patient indicate that some of these individuals are inherently epileptic.
